Aberrant Accumulation of Kras-dependent Pervasive Transcripts During Tumor Progression Renders Cancer Cells Dependent on PAF1 Expression.

Xinhong Liu,Xiangzheng Liu,Yingxue Du,Di Zou,Chen Tian,Yong Li,Xun Lan,Charles J. David,Qianwen Sun,Mo Chen

DOI: https://doi.org/10.1016/j.celrep.2023.112979

IF: 8.8

2023-01-01

Cell Reports

Abstract:KRAS is the most commonly mutated oncogene in human cancer, and mutant KRAS is responsible for over 90% of pancreatic ductal adenocarcinoma (PDAC), the most lethal cancer. Here, we show that RNA polymerase II-associated factor 1 complex (PAF1C) is specifically required for survival of PDAC but not normal adult pancreatic cells. We show that PAF1C maintains cancer cell genomic stability by restraining overaccumulation of enhancer RNAs (eRNAs) and promoter upstream transcripts (PROMPTs) driven by mutant Kras. Loss of PAF1C leads to cancer-specific lengthening and accumulation of pervasive transcripts on chromatin and concomitant aberrant R-loop formation and DNA damage, which, in turn, trigger cell death. We go on to demonstrate that the global transcriptional hyperactivation driven by Kras signaling during tumorigenesis underlies the specific demand for PAF1C by cancer cells. Our work provides insights into how enhancer transcription hyperactivation causes general transcription factor addiction during tumorigenesis.